Response post first autologous stem cell transplantation (ASCT) for multiple myeloma identify patients who may benefit from tandem transplants: A single center prospective phase II study

被引：0
|
作者：
Moreb, Jan S. [1 ]
Salmasinia, Donya [1 ]
Leather, Helen [1 ]
Davis, Amy [1 ]
Hsu, Jack [1 ]
Wiggins, Laura [1 ]
Cogle, Christopher R. [1 ]
Chang, Myron N. [1 ]
Wingard, John R. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4618
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4618
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Leopard: A Phase II Study of Maintenance Lenalidomide and Prednisolone Post Autologous Stem Cell Transplantation (ASCT) for Myeloma, Incorporating Minimal Residual Disease Assessments
    Kalff, Anna
    Kennedy, Nola
    Walker, Patricia A.
    Khong, Tiffany T.
    Schwarer, Anthony
    Roberts, Andrew W.
    Campbell, Philip
    Filshie, Robin
    Smiley, Angela
    Gorniak, Malgorzata
    Black, Marion
    Jenkins, Nicole
    Raines, Geoffrey
    Spencer, Andrew
    BLOOD, 2014, 124 (21)
  • [32] Outcomes of Patients with Multiple Myeloma Following Autologous Stem Cell Transplant According to Post-Transplant Time of Response: A Single Center Experience of 148 Consecutive Transplants
    Ma'koseh, Mohammad
    Al-Essa, Mohammad
    Abu-Jazar, Husam
    Halahleh, Khalid
    Daana, Walid
    Al-Far, Rozan
    Saadeh, Salwa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S329 - S329
  • [33] Daratumumab (dara) as maintenance therapy after autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): results of a phase 2 study
    Borogovac, Azra
    Pichiorri, Flavia
    Matous, Jeffrey
    Berdeja, Jesus
    Pozhitkov, Alexander
    Tandoh, Theophilus
    Chowdhury, Arnab
    Sanchez, James
    Palmer, Joycelynne
    Morales, Ann
    Keats, Jonathan
    Goldsmith, Scott
    Htut, Myo
    Janakiram, Murali
    Nathwani, Nitya
    Rosenzweig, Michael
    Krishnan, Amrita
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S107 - S108
  • [34] Efficacy and Safety of Single Versus Tandem Autologous Stem Cell Transplantation in Multiple Myeloma: A Single-Center Retrospective Analysis in China
    Qiu, Zongjian
    Li, Xiaofan
    Zhan, Rong
    Li, Nainong
    BLOOD, 2023, 142
  • [35] Feasibility and benefits of a structured prehabilitation programme prior to autologous stem cell transplantation (ASCT) in patients with myeloma; a prospective feasibility study
    Mawson, Susan
    Keen, Carol
    Skilbeck, Julie
    Ross, Helen
    Smith, Lauren
    Dixey, Joanne
    Walters, Stephen J.
    Simpson, Rebecca
    Greenfield, Diana M.
    Snowden, John A.
    PHYSIOTHERAPY, 2021, 113 : 88 - 99
  • [36] Outcomes of Maintenance Treatment Post Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients: A Canadian Single Center Experience
    Dehghani, Mina
    Philip, Shona
    Quint, Anthony
    Siqueira, Lenicio
    Lam, Selay
    Phua, Chai Wye
    Xenocostas, Anargyros
    Deotare, Uday
    Louzada, Martha L.
    BLOOD, 2021, 138
  • [37] The relevance of minimal residual disease after autologous stem cell transplantation in patients with multiple myeloma (first results of a prospective study)
    Solovev, M.
    Mendeleeva, L.
    Galtseva, I.
    Pokrovskaya, O.
    Firsova, M.
    Nareyko, M.
    Kuzmina, L.
    Gemdzhian, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S506 - S507
  • [38] Full Dose or Reduced Dose Melphalan (MEL) for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): A Single Center Analysis on 187 Consecutive Patients
    Brioli, Annamaria
    Felix, vom Hofe
    Muegge, Lars-Olof
    Scholl, Sebastian
    Hilgendorf, Inken
    Sayer, Herbert G.
    Yomade, Olaposi
    Ernst, Thomas
    Hochhaus, Andreas
    von Lilienfeld-Toal, Marie
    BLOOD, 2018, 132
  • [39] Prospective tandem autologous stem cell transplantation (ASCT) in patients with refractory and unfavorable relapse from Hodgkin's lymphoma (HL)
    Bouabdallah, R
    Morschauser, F
    Diviné, M
    Leblond, V
    Stamatoullas, A
    Bélanger, C
    Colombat, P
    Brice, P
    BONE MARROW TRANSPLANTATION, 2002, 29 : S9 - S9
  • [40] A phase II study of sequential velcade/thalidomide/dexamethasone as maintenance therapy post single autologous peripheral stem cell in patients with multiple myeloma
    Sahebi, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S148 - S148
12345